Isolated monoclonal antibodies are disclosed herein that specifically bind endoplasmin. In some embodiments these antibodies are fully human. Recombinant nucleic acids encoding these antibodies, expression vectors including these nucleic acids, and host cells transformed with these expression vectors are also disclosed herein. In several embodiments the disclosed antibodies are of use for detecting and/or treating tumors that express endoplasmin, such as melanoma, breast cancer, head and neck squamous cell carcinoma, renal cancer, lung cancer, glioma, bladder cancer, ovarian cancer or pancreatic cancer. In one example, the tumor is a melanoma
An isolated monoclonal antibody or fragment thereof binding prostate specific membrane antigen (PSMA...
Tumor development is based on mutations of genes involved in cell growth (e.g. transcription factors...
Emergence of tumor-targeting antibodies such as Trastuzumab, Rituximab, and Ipilimumab has highlight...
The aim of this study was to analyze whether a monoclonal antibody to human milk fat globule membran...
The use of monoclonal antibodies (mAbs) and molecules derived from them has achieved considerable at...
Abstract In the last two decades there is substantial development in the diagnostic and therapy of m...
The identification of tumor-specific cell surface antigens is a critical step toward the development...
Tumor-specific cell-surface antigens have been clearly demonstrated on experimentally induced animal...
For treatment of benign and malignant tumors it is desirable to find more specific and less burdenin...
Immunoscintigraphy offers the possibility of specifically targeting human tumors, but the complexity...
Despite the major advances in conventional forms of treatment (i.e. surgical tech-niques, radiothera...
Carcinoembryonic antigen related cell adhesion molecule (CEACAM) 6 is over-expressed in different ty...
The growing understanding of the molecular mechanisms of carcinogenesis accelerated the development ...
Although mainly developed for preclinical research and therapeutic use, antibodies have high antigen...
A radiolabeled monoclonal antibody (MAb) that has been shown to react specifically in vitro and ex v...
An isolated monoclonal antibody or fragment thereof binding prostate specific membrane antigen (PSMA...
Tumor development is based on mutations of genes involved in cell growth (e.g. transcription factors...
Emergence of tumor-targeting antibodies such as Trastuzumab, Rituximab, and Ipilimumab has highlight...
The aim of this study was to analyze whether a monoclonal antibody to human milk fat globule membran...
The use of monoclonal antibodies (mAbs) and molecules derived from them has achieved considerable at...
Abstract In the last two decades there is substantial development in the diagnostic and therapy of m...
The identification of tumor-specific cell surface antigens is a critical step toward the development...
Tumor-specific cell-surface antigens have been clearly demonstrated on experimentally induced animal...
For treatment of benign and malignant tumors it is desirable to find more specific and less burdenin...
Immunoscintigraphy offers the possibility of specifically targeting human tumors, but the complexity...
Despite the major advances in conventional forms of treatment (i.e. surgical tech-niques, radiothera...
Carcinoembryonic antigen related cell adhesion molecule (CEACAM) 6 is over-expressed in different ty...
The growing understanding of the molecular mechanisms of carcinogenesis accelerated the development ...
Although mainly developed for preclinical research and therapeutic use, antibodies have high antigen...
A radiolabeled monoclonal antibody (MAb) that has been shown to react specifically in vitro and ex v...
An isolated monoclonal antibody or fragment thereof binding prostate specific membrane antigen (PSMA...
Tumor development is based on mutations of genes involved in cell growth (e.g. transcription factors...
Emergence of tumor-targeting antibodies such as Trastuzumab, Rituximab, and Ipilimumab has highlight...